Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Locally Advanced or Metastatic ER+ HER2- Breast Cancer|Locally Advanced or Metastatic Castration-resistant Prostate Cancer|Locally Advanced or Metastatic Non-small Cell Lung Cancer
Interventions: DRUG: PF-07248144|DRUG: Fulvestrant|DRUG: Letrozole|DRUG: Palbociclib|DRUG: PF-07220060
Sponsor: Pfizer